Evidence map›Paper›PMID 40322425›Full record

ArticleCureus2025

A Rare Atypical Presentation of Bruns-Garland Syndrome: A Case Report and Review of Pathophysiology and Management.

Marco A Orsini, Marcos R de Freitas, Marco A Araujo Leite, Wilhelmina N Hauwanga, Aung Ko Oo, Uzma Nezam, Thiago De Mello Tavares, Muskan Garg, Billy McBenedict, Bruno Lima Pessôa

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marco A OrsiniNeurology, Federal University of Rio de Janeiro, Rio de Janeiro, BRA.
Marcos R de FreitasNeurology, Federal University of Rio de Janeiro, Rio de Janeiro, BRA.
Marco A Araujo LeiteNeurology, Fluminense Federal University, Niterói, BRA.
Wilhelmina N HauwangaCardiology, Gaffrée and Guinle University Hospital, Federal University of the State of Rio de Janeiro, Rio de Janeiro, BRA.
Aung Ko OoFaculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, AUS.
Uzma NezamFaculty of Medicine and Stomatology, Tbilisi State Medical University, Tbilisi, GEO.
Thiago De Mello TavaresFamily Medicine, Universidade Federal de Santa Catarina, Florianópolis, BRA.
Muskan GargGeneral Surgery, Lokmanya Tilak Municipal Medical College, Mumbai, IND.
Billy McBenedictNeurosurgery, Fluminense Federal University, Niterói, BRA.
Bruno Lima PessôaNeurosurgery, Fluminense Federal University, Niterói, BRA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bruns-Garland Syndrome (BGS), also known as diabetic lumbosacral radiculoplexus neuropathy (DLRPN) or diabetic amyotrophy, is a rare diabetic complication causing progressive muscle weakness, neuropathic pain, and functional impairment. It primarily affects individuals with long-standing type II diabetes, with an underlying mechanism of microvasculitis-induced ischemic injury to the lumbosacral plexus, leading to axonal loss and neurogenic atrophy. We present the case of a 73-year-old physician with type II diabetes who developed progressive thigh weakness and sensory deficits over seven years. Neurological examination revealed amyotrophy, paresis in the pelvic girdle muscles, and absent deep tendon reflexes. Electroneuromyography (ENMG) demonstrated chronic neuro-radiculopathy with significant axonal loss, and MRI showed bilateral muscle atrophy, edema, and fatty replacement. Unlike typical BGS cases, which present acutely with unilateral symptoms, this patient exhibited a chronic, bilaterally progressive form, highlighting diagnostic challenges. Differential diagnoses included chronic inflammatory demyelinating polyradiculoneuropathy, lumbar spinal stenosis, and neoplastic neuropathies. Management focused on glycemic control, physical therapy, and neuropathic pain management, with consideration of immunomodulatory therapy in severe cases. This case underscores the need for heightened clinical awareness of atypical BGS presentations and the role of electrodiagnostic and imaging studies in distinguishing it from other neuropathies. Early recognition and comprehensive management are crucial to improving outcomes and preventing further functional decline.

Indexed as

bruns-garland syndromediabetic amyotrophydiabetic lumbosacral radiculoplexus neuropathy (dlrpn)diabetic neuropathyelectroneuromyography (enmg)lumbosacral plexopathymicrovasculitis-induced neuropathyneurogenic muscle atrophyperipheral nerve dysfunctionproximal diabetic neuropathy

Identifiers

PMID40322425
PMCPMC12049857

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.